Vertex posts Phase 4 results for suzetrigine in post-surgical acute painNov 16Trial updatesuzetrigineVertex Pharmaceuticals Inc / Ma
Vertex completes Phase 4 study of suzetrigine for opioid use after knee replacementNov 12Trial updatesuzetrigineVertex Pharmaceuticals Inc / Ma
Vertex raises 2026 revenue guidance, reports Crinetics deal close and povetacicept PDUFA dateNov 2Quarterly updatepovetaciceptVertex Pharmaceuticals Inc / Ma
Vertex Phase 1 study compares VX-581 tablet and suspension formulations in healthy adultsOct 30Weekly roundup, 3 itemssuzetrigineVertex Pharmaceuticals Inc / Ma
Vertex collaborator registers exploratory trial of Journavx for ankle replacement painAug 31Trial updatesuzetrigineVertex Pharmaceuticals Inc / Ma